Ropes & Gray Advised On HAS' Acquisition Of Cerbios-Pharma Backed By 65 Equity Partners

Ropes & Gray Advised Hooters of America on Chapter 11 Bankruptcy Filing

Ropes & Gray has advised 65 Equity Partners, global investment firm, on the planned acquisition of Cerbios-Pharma SA (‘Cerbios’) by HAS Healthcare Advanced Synthesis SA. Cerbios is a world- renowned manufacturer of chemical and biological APIs including in the fast-developing area of antibody drug conjugates while HAS is a leading international developer and producer of active pharmaceutical ingredients, high-potency active pharmaceutical ingredients, and anticancer compounds. Both companies are based out of Switzerland and sell worldwide. 

Backing the merger is 65 Equity Partners which is partnering with these entrepreneurs and family businesses in the acquisition and merger process to drive long-term company growth and innovation. 65 Equity Partners becomes a c.40% shareholder in the combined company alongside the Braglia family which retains majority ownership as part of the deal.

The combination of Cerbios and HAS creates a highly complementary and integrated leader in the Contract Development and Manufacturing Organisation industry. The merged entity will bring extensive production, chemical and biological expertise, technical excellence and a wider range of services to meet the evolving needs of the global pharma industry. 

Leading the Ropes & Gray team was private equity partner John Newton with support from associates Sam Wolfe-Murray, Kenan Ceylan and Max Banister-Buffery. Tax partner Chris Agnoli and associate Charles Voisey, life sciences partner Lincoln Tsang and associates Austin Laroche and Daisy Bray, and litigation & enforcement trainee Simran Gill provided additional support. 

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.